scholarly journals Artificial extracellular matrix - a promising approach to enhance new bone formation in critical size bone defects

2016 ◽  
Vol 4 ◽  
Author(s):  
F�rster Yvonne ◽  
Hintze Vera ◽  
M�ller Stefanie ◽  
Schnabelrauch Matthias ◽  
Scharnweber Dieter ◽  
...  
Keyword(s):  
Extracellular Matrix ◽  
Bone Formation ◽  
Critical Size ◽  
Bone Defects ◽  
New Bone Formation ◽  
Artificial Extracellular Matrix

scholarly journals Evaluation of Amniotic-Derived Membrane Biomaterial as an Adjunct for Repair of Critical Sized Bone Defects

2014 ◽  
Vol 2014 ◽  
pp. 1-4 ◽  
Author(s):  
Mikael Starecki ◽  
John A. Schwartz ◽  
Daniel A. Grande
Keyword(s):  
Bone Formation ◽  
Bone Graft ◽  
Critical Size ◽  
Bone Defects ◽  
Autogenous Bone Graft ◽  
Autogenous Bone ◽  
New Bone Formation ◽  
Group 3 ◽  
Group 2 ◽  
Group 1

Introduction. Autogenous bone graft is the gold standard in reconstruction of bone defects. The use of autogenous bone graft is problematic because of limited bone as well as donor site morbidity. This study evaluates a novel biomaterial as an alternative to autogenous bone graft. The biomaterial is amniotic membrane, rich in growth factors. Methods. Twenty-one adult male Sprague-Dawley rats were implanted with biomaterial using the rat critical size femoral gap model. After creation of the critical size femoral gap animals were randomized to one of the following groups: Group 1 (control): gap left empty and received no treatment; Group 2 (experimental): the gap was filled with commercially available bone graft; Group 3 (experimental): the gap was filled with bone graft plus NuCel amniotic tissue preparation. Results. The experimental groups demonstrated new bone formation compared to controls. The results were evident on radiographs and histology. Histology showed Group 1 controls to have 11.1% new bone formation, 37.8% for Group 2, and 49.2% for Group 3. These results were statistically significant. Conclusions. The study demonstrates that amniotic membrane products have potential to provide bridging of bone defects. Filling bone defects without harvesting autogenous bone would provide a significant improvement in patient care.

scholarly journals Mechanistic Illustration: How Newly-Formed Blood Vessels Stopped by the Mineral Blocks of Bone Substitutes Can Be Avoided by Using Innovative Combined Therapeutics

Biomedicines ◽  
2021 ◽  
Vol 9 (8) ◽  
pp. 952
Author(s):  
Fabien Bornert ◽  
François Clauss ◽  
Guoqiang Hua ◽  
Ysia Idoux-Gillet ◽  
Laetitia Keller ◽  
...  
Keyword(s):  
Regenerative Medicine ◽  
Bone Formation ◽  
Medicinal Product ◽  
Blood Vessels ◽  
Bone Substitute ◽  
Bone Substitutes ◽  
Bone Defects ◽  
New Bone Formation ◽  
Polymeric Component ◽  
Bone Filling

One major limitation for the vascularization of bone substitutes used for filling is the presence of mineral blocks. The newly-formed blood vessels are stopped or have to circumvent the mineral blocks, resulting in inefficient delivery of oxygen and nutrients to the implant. This leads to necrosis within the implant and to poor engraftment of the bone substitute. The aim of the present study is to provide a bone substitute currently used in the clinic with suitably guided vascularization properties. This therapeutic hybrid bone filling, containing a mineral and a polymeric component, is fortified with pro-angiogenic smart nano-therapeutics that allow the release of angiogenic molecules. Our data showed that the improved vasculature within the implant promoted new bone formation and that the newly-formed bone swapped the mineral blocks of the bone substitutes much more efficiently than in non-functionalized bone substitutes. Therefore, we demonstrated that our therapeutic bone substitute is an advanced therapeutical medicinal product, with great potential to recuperate and guide vascularization that is stopped by mineral blocks, and can improve the regeneration of critical-sized bone defects. We have also elucidated the mechanism to understand how the newly-formed vessels can no longer encounter mineral blocks and pursue their course of vasculature, giving our advanced therapeutical bone filling great potential to be used in many applications, by combining filling and nano-regenerative medicine that currently fall short because of problems related to the lack of oxygen and nutrients.

scholarly journals Role of Autologous Platelet Gel (APG) in Bone Healing: A Rabbit Study

2021 ◽  
Vol 11 (1) ◽  
pp. 395
Author(s):  
Antonio Scarano ◽  
Francesco Inchingolo ◽  
Biagio Rapone ◽  
Alberta Greco Lucchina ◽  
Erda Qorri ◽  
...  
Keyword(s):  
Critical Size ◽  
Bone Defects ◽  
New Bone Formation ◽  
Platelet Gel ◽  
Woven Bone ◽  
Rapid Healing ◽  
Rabbit Bone ◽  
Autologous Platelet ◽  
New Zealand Rabbits

Purpose: The aim of the present study is to evaluate the influence and efficacy of autologous platelets on bone regeneration in a rabbit defects model. Materials and Methods: A total of 12 critical size tibial defects were produced in six New Zealand rabbits: A total of six defects were filled with autologous platelet gel (APG) and six defects were maintained as untreated controls. No membranes were used to cover the bone osteotomies. The histology and histomorphometry were performed at four weeks on retrieved samples of both groups. Results: No complications were reported in any of the animals nor for the defects produced. A significantly higher lamellar and woven bone percentage was reported for the APG group with a lower level of marrow spaces (p < 0.05). Evidence of newly formed bone was found in the superficial portion of the bone defect of APG samples where no aspects of bone resorption were observed. Conclusions: The evidence of the present research revealed that APG increases new bone formation restricted to the cortical portion and induces more rapid healing in rabbit bone defects than in untreated defects.

Bioactivity of the Two Kinds of Biodegradable Composite Membrane Containing Oriented Needle-Like Apatite

2005 ◽  
Vol 284-286 ◽  
pp. 811-814 ◽  
Author(s):  
Toshiki Itoh ◽  
Seiji Ban ◽  
T. Watanabe ◽  
Shozo Tsuruta ◽  
Takahiro Kawai ◽  
...  
Keyword(s):  
Bone Formation ◽  
Composite Membrane ◽  
Composite Membranes ◽  
Bone Defects ◽  
Thigh Muscle ◽  
Poly Lactic Acid ◽  
New Bone Formation ◽  
Biodegradable Composite ◽  
Morphogenetic Protein ◽  
Old Mice

It is well known that bone morphogenetic protein (BMP) induces bone formation and requires for carriers. Poly-lactic acid / poly-glycolic acid (PLGA) is frequently used as the carriers of BMP. We developed a biodegradable composite PLGA membrane, which was containing oriented needle-like apatite with BMP. The composite membranes were implanted into the thigh muscle pouch of 3-week-old-mice. At 3 weeks after implantation, the implanted area was observed by optical microscopy. The composite membrane containing oriented needle-like apatite with BMP induced new bone formation. It seems that this composite membrane might be a scaffold of BMP and promoting the healing of bone defects.

scholarly journals Osseous Healing in Surgically Prepared Bone Defects Using Different Grafting Materials: An Experimental Study in Pigs

2020 ◽  
Vol 8 (1) ◽  
pp. 7 ◽  
Author(s):  
Savvas Titsinides ◽  
Theodore Karatzas ◽  
Despoina Perrea ◽  
Efstathios Eleftheriadis ◽  
Leonidas Podaropoulos ◽  
...  
Keyword(s):  
Bone Formation ◽  
Bone Repair ◽  
Healing Process ◽  
Bone Substitutes ◽  
Bone Defects ◽  
New Bone Formation ◽  
Post Surgery ◽  
Beta Tricalcium Phosphate ◽  
Close Proximity ◽  
Tissue Specimens

Regeneration of large jaw bone defects still remains a clinical challenge. To avoid incomplete bone repair, bone grafts have been advocated to support the healing process. This study comparatively evaluated new bone formation among a synthetic graft substitute, a human bone derivative, and a bovine xenograft. Materials were placed in 3 out of the 4 bone cavities, while 1 deficit was left empty, serving as a control, in mono-cortical defects, surgically prepared in the porcine calvaria bone. Animals were randomized in 2 groups and euthanized at 8 and 12 weeks. Harvested tissue specimens were qualitatively evaluated by histology. New bone formation was quantitatively measured by histomorphometry. Maximum new bone formation was noticed in defects grafted with beta-tricalcium phosphate b-TCP compared to the other bone substitutes, at 8 and 12 weeks post-surgery. Bovine and human allograft induced less new bone formation compared to empty bone cavity. Histologic analysis revealed that b-TCP was absorbed and substituted significantly, while bovine and human allograft was maintained almost intact in close proximity with new bone. Based on our findings, higher new bone formation was detected in defects filled with b-TCP when compared to bovine and human graft substitutes.

Evaluation in cats of a new material for cranioplasty: a composite of plaster of Paris and hydroxylapatite

1988 ◽  
Vol 69 (2) ◽  
pp. 269-275 ◽  
Author(s):  
Charles E. Rawlings ◽  
Robert H. Wilkins ◽  
Jacob S. Hanker ◽  
Nicholas G. Georgiade ◽  
John M. Harrelson
Keyword(s):  
Bone Formation ◽  
Frontal Sinus ◽  
Wound Dehiscence ◽  
Bone Defects ◽  
The Body ◽  
New Bone Formation ◽  
Content Type ◽  
Plaster Of Paris ◽  
New Material ◽  
Fine Print

✓ The materials ordinarily used to reconstruct bone defects in the calvaria and facial bones either are difficult to shape, are partially resorbed by the body, or are likely to become infected if used near a contaminated area such as the frontal sinus. Calcium sulfate hemihydrate (plaster of Paris) has been known for years to have excellent reparative qualities in bone defects, but ordinarily it is quickly resorbed. Consequently, a new material, a composite of a dense form of plaster of Paris and hydroxylapatite, was devised to provide nonabsorbable hydroxylapatite particles for bone to form around and within during the phase of plaster absorption. Two types of this material were evaluated in cranial defects in cats. Each of the plaster of Paris/hydroxylapatite mixtures was placed into a surgically unroofed frontal sinus and into a contralateral parietal trephine hole in a group of 32 cats. Two cats in each group succumbed to anesthesia, leaving two sets of 30 cats. During the entire follow-up period there was only one other death, with no evidence of wound infection, wound dehiscence, implant rejection, or cerebral dysfunction among the survivors. The cats in each group were sacrificed at 1, 2, 3, 5, 7, 8, 9, 10, or 12 months after operation. Following sacrifice, both the frontal and parietal defects were exposed and examined visually, histologically, and with histomorphometric analysis for new bone formation. New bone formation was present as early as 1 month after operation and continued to increase during the 12 months of the study. Based upon these osteogenic qualities, the ease of shaping the composite, and the lack of infection in the frontal sinus region, it is concluded that this substance could be a valuable new material for human cranioplasty.

A Review of Two Animal Studies Dealing with Biological Responses to Glass-Fibre-Reinforced Composite Implants in Critical Size Calvarial Bone Defects in Rabbits

2007 ◽  
Vol 361-363 ◽  
pp. 471-474 ◽  
Author(s):  
Sari Tuusa ◽  
Matti Peltola ◽  
Teemu Tirri ◽  
Lippo Lassila ◽  
Pekka K. Vallittu
Keyword(s):  
Bone Formation ◽  
Bioactive Glass ◽  
Inflammatory Reaction ◽  
Glass Fibre ◽  
Critical Size ◽  
Bone Defects ◽  
Resin System ◽  
Connective Tissues ◽  
Reinforced Composite ◽  
Glass Fibre Reinforced

In these studies, E-glass-fibre-reinforced composite (FRC) implants with photopolymerisable resin systems and bioactive glass granules (BAG) were evaluated as a reconstructive material in the critical size bone defects made to rabbits’ calvarial bones. In the first study, a new experimental resin system, DD1/MMA/BDDMA, was used to impregnate the doubleveil FRC-implants, while in the second study, a commercial resin system composed of BisGMA/MMA/PMMA was used in impregnation. These double-veil FRC-implants were coated with bioactive glass granules (BAG, 315-500 0m). In the second study, an experimental FRC consisting of two laminates of woven fibres, was also tested as an implant material. These implants were filled with BAG-granules and pure fused quartz fibers (Quartzel wool). In the first study, implantation time was 4 or 12 weeks, while in the second study, it was 12 weeks for both the implant types. Results: In the first study, the healing of the defects had started in the form of new bone growth from the defect margins, as well as small islands of woven bone in the middle of the defect, at 4 weeks postoperatively. Ingrowth of dense connective tissue into the pores of the implant was widely seen. At 12 weeks postoperatively, more bony islands were seen as compared to the animals studied at 4 weeks. Part of the newly formed bone had an appearance of lamellar structure. The porous structures of the implant were deeply filled with fibroconnective tissue. Ingrowth of maturing bone to the implant structures was occasionally seen. The inflammatory reaction was moderate, and was mostly found inside the upper part of the implant. In the second study, inflammatory reactions caused by both types of the FRC implants were very slight. Small amount of new bone had started to grow from the defect margins in doulble-veil implanted defects. No ingrowth of connective tissues or new bone formation was seen inside these implants. Instead, both the connective tissues and newly formed, mineralizing bone were seen inside the experimental double-laminate implants. SiO2-fibres seemed to cause moderate inflammatory reaction inside the implants, while BAG granules did not. In both the study groups, the brain tissue was oedemic, but no obvious serious damage was found. Conclusions: The structural properties of the FRC-implants had an influence on the healing process of the bone defect. BAG, as a constituent of the FRCimplants, enhanced the bone formation process. After some modifications to the properties of the FRC, this type of implant has possibilities to become one material alternative in clinical bone defect reconstruction at the craniofacial area in the future.

Collagen/glycosaminoglycan coatings enhance new bone formation in a critical size bone defect — A pilot study in rats

2017 ◽  
Vol 71 ◽  
pp. 84-92 ◽  
Author(s):  
Yvonne Förster ◽  
Ricardo Bernhardt ◽  
Vera Hintze ◽  
Stephanie Möller ◽  
Matthias Schnabelrauch ◽  
...  
Keyword(s):  
Pilot Study ◽  
Bone Formation ◽  
Bone Defect ◽  
Critical Size ◽  
New Bone Formation
Sign in / Sign up

Export Citation Format

Share Document